Skip to main content
SpringerLink
Log in

The Multiphase Optimization Strategy for Engineering Effective Tobacco Use Interventions

  • Original Article
  • Published:
Annals of Behavioral Medicine

Abstract

The multiphase optimization strategy (MOST) is a new methodological approach for building, optimizing, and evaluating multicomponent interventions. Conceptually rooted in engineering, MOST emphasizes efficiency and careful management of resources to move intervention science forward steadily and incrementally. MOST can be used to guide the evaluation of research evidence, develop an optimal intervention (the best set of intervention components), and enhance the translation of research findings, particularly type II translation. This article uses an ongoing study to illustrate the application of MOST in the evaluation of diverse intervention components derived from the phase-based framework reviewed in the companion article by Baker et al. (Ann Behav Med, in press, 2011). The article also discusses considerations, challenges, and potential benefits associated with using MOST and similar principled approaches to improving intervention efficacy, effectiveness, and cost-effectiveness. The applicability of this methodology may extend beyond smoking cessation to the development of behavioral interventions for other chronic health challenges.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Baker TB, Mermelstein R, Collins LM, et al. New methods for tobacco dependence treatment research. Ann Behav Med. 2011; in press.

  2. Fiore MC, Bailey WC, Cohen SJ. Treating tobacco use and dependence: Clinical practice guideline. Rockville: U.S. Department of Health and Human Services, U.S. Public Health Service; 2000.

    Google Scholar 

  3. Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Rockville: U.S. Department of Health and Human Services, U.S. Public Health Service; 2008.

    Google Scholar 

  4. Collins LM, Murphy SA, Nair VN, Strecher VJ. A strategy for optimizing and evaluating behavioral interventions. Ann Behav Med. 2005;30(1):65–73.

    Article  PubMed  Google Scholar 

  5. Collins LM, Murphy SA, Strecher V. The Multiphase Optimization Strategy (MOST) and the Sequential Multiple Assignment Randomized Trial (SMART): New methods for more potent eHealth interventions. Am J Prev Med. 2007;32(5 Suppl):S112–8.

    Article  PubMed  Google Scholar 

  6. Hollis JF, Bills R, Whitlock E, Stevens VJ, Mullooly J, Lichtenstein E. Implementing tobacco interventions in the real world of managed care. Tob Control. 2000;9(Suppl 1):I18–124.

    Article  PubMed  Google Scholar 

  7. Hung DY, Shelley DR. Multilevel analysis of the Chronic Care Model and 5A services for treating tobacco use in urban primary care clinics. Health Serv Res. 2008;44:103–27.

    Article  PubMed  Google Scholar 

  8. Kottke TE, Solberg LI, Brekke ML, Cabrera A, Marquez MA. Delivery rates for preventive services in 44 Midwestern clinics. Mayo Clin Proc. 1997;72(6):515–23.

    Article  PubMed  CAS  Google Scholar 

  9. Glasgow RE, Emmons KM. How can we increase translation of research into practice? Types of evidence needed. Annu Rev Public Health. 2007;28:413–33.

    Article  PubMed  Google Scholar 

  10. Glasgow RE, Lichtenstein E, Marcus AC. Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health. 2003;93(8):1261–7.

    Article  PubMed  Google Scholar 

  11. Box GEP, Hunter, W.G., & Hunter, J.S. Statistics for experimenters: An introduction to design, data analysis, and model building. New York: Wiley; 1978.

    Google Scholar 

  12. Wu CF, Hamada M. Experiments: Planning, analysis, and parameter design optimization. New York: Wiley; 2000.

    Google Scholar 

  13. Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Boston: Houghton-Mifflin; 2002.

    Google Scholar 

  14. Campbell MK, Mollison J, Steen N, Grimshaw JM, Eccles M. Analysis of cluster randomized trials in primary care: A practical approach. Fam Pract. 2000;17(2):192–6.

    Article  PubMed  CAS  Google Scholar 

  15. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ. 2008;337:a1655.

    Article  PubMed  Google Scholar 

  16. Rose JE, Behm FM, Westman EC, Kukovich P. Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res. 2006;8(1):89–101.

    Article  PubMed  CAS  Google Scholar 

  17. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: Systematic review and meta-analysis. BMJ. 2009;338:b1024.

    Article  PubMed  Google Scholar 

  18. Hughes JR, Carpenter MJ. The feasibility of smoking reduction: An update. Addiction. 2005;100(8):1074–89.

    Article  PubMed  Google Scholar 

  19. Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control. 2007;16 Suppl 1:i53–9.

    Article  PubMed  Google Scholar 

  20. Zhu SH, Stretch V, Balabanis M, Rosbrook B, Sadler G, Pierce JP. Telephone counseling for smoking cessation: Effects of single-session and multiple-session interventions. J Consult Clin Psychol. 1996;64(1):202–11.

    Article  PubMed  CAS  Google Scholar 

  21. Zhu SH, Tedeschi G, Anderson CM, et al. Telephone counseling as adjuvant treatment for nicotine replacement therapy in a “real-world” setting. Prev Med. 2000;31(4):357–63.

    Article  PubMed  CAS  Google Scholar 

  22. Zhu SH, Anderson CM, Tedeschi GJ, et al. Evidence of real-world effectiveness of a telephone quitline for smokers. New Engl J Med. 2002;347(14):1087–93.

    Article  PubMed  Google Scholar 

  23. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial. JAMA. 2006;296(1):64–71.

    Article  PubMed  CAS  Google Scholar 

  24. Covey LS, Glassman AH, Jiang H, et al. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. Addiction. 2007;102(8):1292–302.

    Article  PubMed  Google Scholar 

  25. Hays JT, Hurt RD, Rigotti NA, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial. Ann Intern Med. 2001;135(6):423–33.

    PubMed  CAS  Google Scholar 

  26. Dale Horst W, Klein MW, Williams D, Werder SF. Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia. Neuropsychiatr Dis Treat. 2005;1(4):349–55.

    PubMed  CAS  Google Scholar 

  27. Helgason AR, Tomson T, Lund KE, Galanti R, Ahnve S, Gilljam H. Factors related to abstinence in a telephone helpline for smoking cessation. Eur J Public Health. 2004;14(3):306–10.

    Article  PubMed  Google Scholar 

  28. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA. 1994;271(24):1940–7.

    Article  PubMed  CAS  Google Scholar 

  29. Piper ME, Federmen EB, McCarthy DE, et al. Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. J Abnorm Psychol. 2008;117(1):94–105.

    Article  PubMed  Google Scholar 

  30. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. JAMA. 2006;296(1):56–63.

    Article  PubMed  CAS  Google Scholar 

  31. Ferguson SG, Shiffman S, Gwaltney CJ. Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. J Consult Clin Psychol. 2006;74(6):1153–61.

    Article  PubMed  Google Scholar 

  32. Shiffman S, Scharf DM, Shadel WG, et al. Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol. 2006;74(2):276–85.

    Article  PubMed  Google Scholar 

  33. Collins LM, Dziak JJ, Li R. Design of experiments with multiple independent variables: A resource management perspective on complete and reduced factorial designs. Psychol Methods. 2009;14(3):202–24.

    Article  PubMed  Google Scholar 

  34. Fisher RA. The arrangement of field experiments. Journal of the Ministry of Agriculture of Great Britain. 1926;33:505–13.

    Google Scholar 

  35. Chakraborty H. The design and analysis aspects of cluster randomized trials. In: Biswas A, Datta S, Fine JP, Segal MR, eds. Statistical Advances in the Biomedical Sciences. Hoboken: Wiley; 2008:67–80.

    Google Scholar 

  36. SAS Institute. SAS/STAT 9.1 User's Guide. Cary: SAS Institute; 2004.

    Google Scholar 

  37. SAS Institute. SAS/QC9.1 User's Guide. Cary: SAS Institute; 2004.

    Google Scholar 

  38. Rivera DE, Pew MD, Collins LM. Using engineering control principles to inform the design of adaptive interventions: A conceptual introduction. Drug Alcohol Depend. 2007;88 Suppl 2:S31–40.

    Article  PubMed  Google Scholar 

  39. Zafra-Cabeza A, Rivera DE, Collins LM, Riado MA, Camacho EF. A risk-based model predictive control approach to adaptive interventions in behavioral health. Proceedings of the 45th IEEE Conference on Decision and Control. 2006:673–8.

  40. Carroll KM, Rounsaville BJ. Bridging the gap: A hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatr Serv. 2003;54(3):333–9.

    Article  PubMed  Google Scholar 

  41. Carroll KM, Rounsaville BJ. A vision of the next generation of behavioral therapies research in the addictions. Addiction. 2007;102(6):850–62; discussion 63–9.

    Article  PubMed  Google Scholar 

  42. Hopkins DP, Briss PA, Ricard CJ, et al. Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med. 2001;20(2 Suppl):16–66.

    Article  PubMed  CAS  Google Scholar 

  43. Hopkins DP, Husten CG, Fielding JE, Rosenquist JN, Westphal LL. Evidence reviews and recommendations on interventions to reduce tobacco use and exposure to environmental tobacco smoke: A summary of selected guidelines. Am J Prev Med. 2001;20(2 Suppl):67–87.

    Article  PubMed  CAS  Google Scholar 

  44. Glasgow RE, Klesges LM, Dzewaltowski DA, Bull SS, Estabrooks P. The future of health behavior change research: What is needed to improve translation of research into health promotion practice? Ann Behav Med. 2004;27(1):3–12.

    Article  PubMed  Google Scholar 

  45. Glasgow RE, Orleans CT, Wagner EH. Does the chronic care model serve also as a template for improving prevention? Milbank Q. 2001;79(4):579–612, iv–v.

    Article  PubMed  CAS  Google Scholar 

  46. McLellan A, Lewis, DC, O'Brein, CP, Kleber, HD. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689–95.

    Article  PubMed  CAS  Google Scholar 

  47. Hung DY, Rundall TG, Tallia AF, Cohen DJ, Halpin HA, Crabtree BF. Rethinking prevention in primary care: Applying the chronic care model to address health risk behaviors. Milbank Q. 2007;85(1):69–91.

    Article  PubMed  Google Scholar 

  48. Kreps GL, Neuhauser L. New directions in eHealth communication: Opportunities and challenges. Patient Educ Couns. 2010;78(3):329–36.

    Article  PubMed  Google Scholar 

  49. Friend K, Levy DT. Smoking treatment interventions and policies to promote their use: A critical review. Nicotine Tob Res. 2001;3(4):299–310.

    Article  PubMed  CAS  Google Scholar 

  50. Evaluation resources. Available at: www.dhs.ca.gov/tobacco. 2000.

  51. Centers for Disease Control and Prevention. Use of FDA-approved pharmacological treatments for tobacco dependence—United States, 1984–1998. MMWR. 2000;49:665–8.

    Google Scholar 

  52. Rothemich SF, Woolf SH, Johnson RE, et al. Effect on cessation counseling of documenting smoking status as a routine vital sign: An ACORN study. Ann Fam Med. 2008;6(1):60–8.

    Article  PubMed  Google Scholar 

  53. Fiore MC, Bailey WC, Cohen SJ. Smoking cessation: Clinical practice guideline no. 18. Rockville: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1996.

    Google Scholar 

  54. Japuntich SJ, Zehner ME, Smith SS, et al. Smoking cessation via the internet: A randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention. Nicotine Tob Res. 2006;8 Suppl 1:S59–67.

    Article  PubMed  Google Scholar 

  55. Strecher VJ, McClure J, Alexander G, et al. Web-based smoking cessation components and tailoring depth: Results of a randomized trial. Am J Prev Med. 2008;34:373–81.

    Article  PubMed  Google Scholar 

  56. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA. 1994;271(8):589–94.

    Article  PubMed  CAS  Google Scholar 

  57. Collins LM, Murphy SA, Bierman KL. A conceptual framework for adaptive preventive interventions. Prev Sci. 2004;5(3):185–96.

    Article  PubMed  Google Scholar 

  58. Murphy SA, Lynch KG, Oslin D, McKay JR, TenHave T. Developing adaptive treatment strategies in substance abuse research. Drug Alcohol Depend. 2007;88 Suppl 2:S24–30.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This research was supported by a grant 9P50CA143188-11 from the National Cancer Institute. Dr. Collins was supported via grant P50DA10075, from the National Institute on Drug Abuse. Dr. Baker was supported via NCI 1K05CA139871. Dr. Piper was supported by grant 1UL1RR025011 from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources (NCRR), National Institutes of Health (NIH). Dr. Cook was supported by K08DA021311.

Conflicts of Interest

Linda M. Collins, Timothy B. Baker, Robin Mermelstein, Megan E. Piper, Stevens S. Smith, Bruce A. Christiansen, Tanya R. Schlam, and Jessica W. Cook have no potential conflicts of interest to disclose. Douglas E. Jorenby has received research support from the National Institute on Drug Abuse, the National Cancer Institute, Pfizer, Inc., Sanofi-Synthelabo, and Nabi Biopharmaceuticals. He has received support for educational activities from the National Institute on Drug Abuse and the Veterans Administration and consulting fees from Nabi Biopharmaceuticals. Over the last 3 years, Michael C. Fiore served as an investigator on research studies at the University of Wisconsin that were funded by Nabi Biopharmaceuticals.

Author information

Authors and Affiliations

  1. The Pennsylvania State University, University Park, PA, USA

    Linda M. Collins Ph.D.

  2. University of Wisconsin, Madison, WI, USA

    Timothy B. Baker Ph.D., Megan E. Piper Ph.D., Douglas E. Jorenby Ph.D., Stevens S. Smith Ph.D., Bruce A. Christiansen Ph.D., Tanya R. Schlam Ph.D., Jessica W. Cook Ph.D. & Michael C. Fiore MD, MPH, MBA

  3. University of Illinois, Chicago, Chicago, IL, USA

    Robin J. Mermelstein Ph.D.

Authors
  1. Linda M. Collins Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy B. Baker Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robin J. Mermelstein Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Megan E. Piper Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Douglas E. Jorenby Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stevens S. Smith Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bruce A. Christiansen Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tanya R. Schlam Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jessica W. Cook Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michael C. Fiore MD, MPH, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Megan E. Piper Ph.D..

About this article

Cite this article

Collins, L.M., Baker, T.B., Mermelstein, R.J. et al. The Multiphase Optimization Strategy for Engineering Effective Tobacco Use Interventions. ann. behav. med. 41, 208–226 (2011). https://doi.org/10.1007/s12160-010-9253-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12160-010-9253-x

Keywords

Search

Navigation